How many drugs treat Paroxysmal atrial fibrillation?

Drug Landscape tracks 1 marketed treatments for Paroxysmal atrial fibrillation (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/paroxysmal-atrial-fibrillation.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Paroxysmal atrial fibrillation — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Paroxysmal atrial fibrillation (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Paroxysmal atrial fibrillation, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Multaq	DRONEDARONE	Sanofi	Antiarrhythmic [EPC]	Potassium voltage-gated channel subfamily KQT member 2		2009-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Paroxysmal atrial fibrillation
Sanofi · 1 drug in Paroxysmal atrial fibrillation

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Paroxysmal atrial fibrillation:

Cite this brief

Drug Landscape (2026). Paroxysmal atrial fibrillation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/paroxysmal-atrial-fibrillation. Accessed 2026-06-10.

Paroxysmal atrial fibrillation full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing